Pharmaceutical Technology, March 2023

The ability of artificial intelligence to process large amounts of diverse data cleanly creates more accurate reports for improved drug safety.

This article discusses the evaluation of paired content uniformity and weight variation data sets using F and T tests to ensure that batches meet compendial requirements.

Lipids aren’t the only important ingredients influencing stability and in vivo performance.

Advancements in therapeutic modalities are necessitating change in drug delivery to help negate some of the expense of development and manufacturing.

EnteroBiotix is harnessing the power of the microbiome to target an array of diseases.

PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.

Stockpiling excess inventory is no longer enough to respond to supply chain volatility.

Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.

The trends shaping the growth of the biologics outsourcing industry demand attention.

Advances in vaccine development are creating partnerships and stimulating clinical trials to develop new mRNA applications.

Stepwise paediatric investigation plans aim to boost the development of medicines for children.

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.

Soaring energy costs are compounding the challenges currently being faced by the European bio/pharma industry.

Good distribution practices ensure appropriate physical storage, distribution, and supply chain security, says Siegfried Schmitt, vice president, Technical, at Parexel.

The ROSS PDDM Planetary Dual Disperser offers flexibility in the form of removable disperser shafts.

Fluid Air’s Enhanced Magnaflo filter blowback system is designed to increase powder yield in PolarDry Models 001 and 004.

The IsoPick from iotaSciences is designed to expand handling solutions for cell biology and gene therapy applications.

Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

That wave beginning to crash over PhRMA’s gunwales may well emanate from a startup mindset, rather than Big Pharma or government policy pundits.